Methylation levels of sodium-iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression

Methylation levels of sodium-iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression

Author Galrao, A. L. Google Scholar
Sodre, A. K. Google Scholar
Camargo, R. Y. Google Scholar
Friguglietti, C. U. Google Scholar
Kulcsar, M. A. Google Scholar
Lima, E. U. Google Scholar
Medeiros-Neto, G. Google Scholar
Rubio, I. G. S. Autor UNIFESP Google Scholar
Institution Universidade de São Paulo (USP)
Santa Catarina Hosp
ICESP
Universidade Federal de São Paulo (UNIFESP)
Abstract DNA methylation regulates gene expression. Aberrant methylation plays an important role in human tumorigenesis. We have previously detected reduced NIS mRNA expression in thyroid tumors as compared to non-tumor tissues. Thus, in this study we investigated whether the methylation of the CpG-island located in the NIS gene promoter was associated with reduced mRNA expression in thyroid tumors. Methylation levels of 30 pairs of samples from 10 benign and 20 malignant thyroid tumors (T) along with matched non-tumor (NT) areas were determined by semiquantitative methylation specific-PCR. NIS methylation was detected in all samples. Methylation levels and frequencies did not differ between the groups and were not associated with BRAF mutational status. Highest methylation levels and frequencies were detected in the 5' region of the CpG-island decreasing toward the 3' end. Intraindividual analysis (T versus NT) showed high tumor methylation levels in 40 % of the samples in the benign group and 30 % in the malignant group, associated with low NIS mRNA expression. No quantitative correlation was detected between methylation levels and mRNA expression in any the groups. the results of this study showed that methylation of NIS promoter is a very frequent event in both benign and malignant tumors as well as in their surrounding tissues, and characterized a non-homogeneous methylation pattern along the CpG island. Therefore, further investigations involving other sites that may be implicated in methylation regulation of NIS expression are warranted.
Keywords DNA methylation
NIS symporter
Iodine
Thyroid nodule
Thyroid cancer
Language English
Sponsor Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Instituto da Tiroide, São Paulo, Brazil
Grant number FAPESP: 2007/51235-7
FAPESP: 2007/51236-3
FAPESP: 2009/52517-1
Date 2013-02-01
Published in Endocrine. Totowa: Humana Press Inc, v. 43, n. 1, p. 225-229, 2013.
ISSN 1355-008X (Sherpa/Romeo, impact factor)
Publisher Humana Press Inc
Extent 225-229
Origin http://dx.doi.org/10.1007/s12020-012-9779-8
Access rights Closed access
Type Article
Web of Science ID WOS:000313069600033
URI http://repositorio.unifesp.br/handle/11600/35923

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account